文献速递介入腹部外周血管DSA

恶性胆道梗阻患者经皮自膨式金属支架置入后迟发性动脉出血的栓塞治疗

Embolization for delayed arterial bleeding after percutaneous self-expandable metallic stent placement in patients with malignant biliary obstruction.
PubMed 文献 · Br J Radiol · 2019-12-11

回顾性分析1997年1月至2017年9月单中心1858例恶性胆道梗阻经皮自膨式金属支架置入患者,其中19例出现迟发性支架相关动脉出血并接受经导管动脉栓塞治疗。迟发性出血发生率为1.0%(19/1858),中位时间间隔225天;栓塞后所有患者出血停止,总体临床成功率94.7%(18/19),30天死亡率26.3%(5/19),1例(5.3%)发生与门静脉闭塞相关的急性肝衰竭。作者结论认为经导管动脉栓塞对支架置入后迟发性动脉出血安全有效。

要点

  • 恶性胆道梗阻经皮自膨式金属支架置入后迟发性动脉出血发生率为1.0%(19/1858),中位间隔225天。
  • 数字减影血管造影可见支架网旁假性动脉瘤、支架内假性动脉瘤,可伴对比剂外溢至十二指肠或动脉胆管瘘。
  • 经导管动脉栓塞后所有患者出血停止,总体临床成功率94.7%(18/19),1例复发再栓塞成功。

核心结论

  • 经导管动脉栓塞对恶性胆道梗阻经皮自膨式金属支架置入后迟发性动脉出血安全有效。

研究设计与样本

  • 回顾性研究,单中心三级转诊中心,1997年1月至2017年9月共1858例恶性胆道梗阻患者接受经皮自膨式金属支架置入。
  • 其中19例(平均年龄70.2岁,范围52-82岁;男13例)出现迟发性支架相关动脉出血并接受经导管动脉栓塞治疗。
  • 以数字减影血管造影为诊断与治疗依据,评估技术成功、临床成功及并发症。

关键影像表现/征象

  • 数字减影血管造影显示支架网旁单纯假性动脉瘤10例。
  • 支架网旁假性动脉瘤伴对比剂外溢至十二指肠3例。
  • 支架网旁假性动脉瘤伴动脉胆管瘘1例。
  • 支架内单纯假性动脉瘤4例,支架内假性动脉瘤伴动脉胆管瘘1例。

诊断标准与关键数值

  • 迟发性支架相关动脉出血发生率为1.0%(19/1858),中位时间间隔225天(范围22-2296天)。
  • 栓塞后所有患者出血停止,总体临床成功率94.7%(18/19)。
  • 1例复发出血经第二次栓塞治疗成功。
  • 总体30天死亡率为26.3%(5/19)。
  • 主要操作相关并发症为急性肝衰竭1例(5.3%),发生于1例肝门部胆管癌患者,与门静脉闭塞相关。

临床应用与阅片要点

  • 对恶性胆道梗阻经皮自膨式金属支架置入后出现迟发性动脉出血者,数字减影血管造影可识别支架网旁或支架内假性动脉瘤及动脉胆管瘘等出血源。
  • 经导管动脉栓塞可使此类出血停止,临床成功率94.7%(18/19),复发者可再次栓塞。
  • 肝门部胆管癌伴门静脉闭塞者栓塞后需注意急性肝衰竭这一主要操作相关并发症(1例,5.3%)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To retrospectively evaluate the safety and efficacy of transcatheter arterial embolization (TAE) for delayed arterial bleeding secondary to percutaneous self-expandable metallic stent (SEMS) placement in patients with malignant biliary obstruction (MBO).

METHODS: From January 1997 to September 2017, 1858 patients underwent percutaneous SEMS placement for MBO at a single tertiary referral center. Among them, 19 patients (mean age, 70.2 [range, 52-82] years; 13 men) presented with delayed SEMS-associated arterial bleeding and underwent TAE.

RESULTS: The incidence of delayed arterial bleeding was 1.0% (19/1858) after SEMS placement, with a median time interval of 225 days (range, 22-2296). Digital subtraction angiography (DSA) showed pseudoaneurysm alone close to the stent mesh (n = 10), pseudoaneurysm close to the stent mesh with contrast extravasation to the duodenum (n = 3), pseudoaneurysm close to the stent mesh with arteriobiliary fistula (n = 1), in-stent pseudoaneurysm alone (n = 4) and in-stent pseudoaneurysm with arteriobiliary fistula (n = 1). Bleeding was stopped after the embolization in all patients. Overall clinical success rate was 94.7% (18/19). One patient with recurrent bleeding was successfully treated with a second embolization. Overall 30-day mortality rate was 26.3% (5/19). A major procedure-related complication was acute hepatic failure in one hilar bile duct cancer patient (5.3%), which was associated with an obliterated portal vein.

CONCLUSION: TAE is safe and effective for the treatment of delayed arterial bleeding after percutaneous SEMS placement for MBO.

ADVANCES IN KNOWLEDGE: This study demonstrated TAE is safe and effective for arterial bleeding after SEMS placement after MBO through the largest case series so far.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Kim PH, Kim JW, Gwon DI, et al. Embolization for delayed arterial bleeding after percutaneous self-expandable metallic stent placement in patients with malignant biliary obstruction. Br J Radiol. 2019. PMID: 31778313. doi:10.1259/bjr.20190637

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。